Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 June 2009, doi:10.1136/bmj.b2392
Cite this as: BMJ 2009;338:b2392
Tobias Kurth, senior researcher1,2,3,4, Paul E de Jong, professor5, Nancy R Cook, associate professor1,2, Julie E Buring, professor1,2,6,7,8, Paul M Ridker, professor1,2,5,6
1 Division of Preventive Medicine, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston MA, USA, 2 Department of Epidemiology, Harvard School of Public Health, Boston MA, 3 INSERM Unit 708—Neuroepidemiology, Paris, France, 4 Faculty of Medicine, University Pierre et Marie Curie, Paris, France, 5 Department of Internal Medicine, University Medical Center Groningen, Groningen, the Netherlands, 6 Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Womens Hospital, 7 Donald W Reynolds Center for Cardiovascular Research, Department of Medicine, Brigham and Womens Hospital, 8 Department of Ambulatory Care and Prevention, Harvard Medical School
Correspondence to: T Kurth, INSERM Unit 708—Neuroepidemiology, Hôpital de la Pitié-Salpêtrière, 47 boulevard de lHôpital, 75651 Paris Cedex 13, France tkurth{at}rics.bwh.harvard.edu
Design Prospective cohort study.
Setting Womens Health Study, United States.
Participants 27 939 female health professionals aged
45 who were free of cardiovascular disease and other major disease and who provided a blood sample at study entry.
Main outcome measures Time to cardiovascular disease (non-fatal stroke, non-fatal myocardial infarction, coronary revascularisation procedures, or death from cardiovascular cause), specific cardiovascular disease events, and all-cause mortality. End points were confirmed after review of medical records and death certificates.
Results Glomerular filtration rate (GFR) was estimated with the abbreviated Modification of Diet in Renal Disease Study equation. At baseline, 1315 (4.7%) women had GFR <60 ml/min/1.73 m2. During 12 years of follow-up, 1199 incident cardiovascular disease events and 856 deaths (179 from cardiovascular disease) occurred. Compared with women with GFR
90 ml/min/1.73 m2, the multivariable adjusted hazard ratios for any first cardiovascular disease were 0.95 (95% CI 0.83 to 1.08), 0.84 (0.70 to 1.00), and 1.00 (0.79 to 1.27) among women with GFR of 75-89.9, 60-74.9, and <60 ml/min/1.73 m2, respectively; the equivalent hazard ratios for all cause mortality were 0.93 (0.79 to 1.09), 1.03 (0.85 to 1.26), and 1.09 (0.83 to 1.45). Similar null findings were observed for myocardial infarction, stroke, coronary revascularisation, and non-cardiovascular death. However, an increased risk of death from cardiovascular disease was found among women with GFR <60 ml/min/1.73 m2 (hazard ratio 1.68 (1.02 to 2.79)).
Conclusions In this large cohort of women, a glomerular filtration rate <60 ml/min/1.73 m2 was associated with increased risk of cardiovascular disease death but not other cardiovascular disease events or non-cardiovascular disease mortality. We observed no increase in risk of any of the outcomes among women with less severe impairment of kidney function.
© Kurth et al 2009
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses